Ocugen, Inc. Price Today
Ocugen, Inc.
OCGN
Healthcare
$482.22M
💰
Market Cap
0
💸
Price to Earnings
$-0.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
6 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
OCGN Price Forecast Target
1.9 👉 8.0 +326%
OCGN EPS Forecast
-0.3 👉 -0.3 +-12%
Financials
Profit Margin
0 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
1.5% - Insiders
10.3% - Institutions
88.2% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $22.6M
-
💰 Blackrock Inc. $6.9M
-
💰 Geode Capital Management, LLC $5.5M
-
💰 Luminus Management, LLC $3.1M
-
💰 State Street Corporation $1.6M
Stock Ideas
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …📮FAQ
Some Frequently Asked Questions.
The Ocugen, Inc. industry is Biotechnology
The Ocugen, Inc. sector is Healthcare
The Ocugen, Inc. forecasted predicted Price to Earnings PE ratio is -6.7
The Ocugen, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Ocugen, Inc. is $482.22M
There are total of 252377875 float shares with 10.3% held by Institutions and 1.5% held by insiders
The MOcugen, Inc. forecasted Earnings per Share EPS is $-0.3
The Ocugen, Inc. Earnings per Share EPS is -0.3
The Ocugen, Inc. company has $0 gross profits with 0 profit margins
The Ocugen, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Ocugen, Inc. Revenue is $0 with 0 revenue growth
The price target for Ocugen, Inc. stock is $8.0 for the high target and $4.0 for the low target
The consensus analyst recommendations for Ocugen, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Ocugen, Inc. is Buy, with the following breakdown:
- Buy: 6
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of Ocugen, Inc. is 3.7
The dividend of Ocugen, Inc. is $0
The dividend yield of Ocugen, Inc. is 0%
The biggest institutional and mutual fund holders of Ocugen, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Geode Capital Management, LLC
- Luminus Management, LLC
The Ocugen, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0